FibroGen Inc (FGEN)
0.40
+0.05
(+13.09%)
USD |
NASDAQ |
Dec 20, 16:00
0.4048
0.00 (0.00%)
After-Hours: 20:00
FibroGen Shareholders Equity (Quarterly): -243.67M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 5.413B |
| Arbutus Biopharma Corp | 106.89M |
| GlycoMimetics Inc | 11.38M |
| Cidara Therapeutics Inc | 115.63M |
| Cue Biopharma Inc | 25.37M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 264.42M |
| Total Liabilities (Quarterly) | 466.12M |
| Debt to Equity Ratio | -0.2987 |
| Current Ratio | 1.283 |
| Net Debt Paydown Yield | -0.68% |